Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase.
暂无分享,去创建一个
C. Samuel | Ping Zhang | C. George | Sonali Das | A. Toth | C. E. Samuel
[1] Alexander Rich,et al. Structure of the DLM-1–Z-DNA complex reveals a conserved family of Z-DNA-binding proteins , 2018, Nature Structural Biology.
[2] C. Samuel,et al. Activation of the RNA-dependent Protein Kinase PKR Promoter in the Absence of Interferon Is Dependent Upon Sp Proteins* , 2006, Journal of Biological Chemistry.
[3] A. Shahangian,et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.
[4] S. Tsuji,et al. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites. , 2005, Gene.
[5] G. Kochs,et al. The interferon response circuit: Induction and suppression by pathogenic viruses , 2005, Virology.
[6] R. Bartenschlager,et al. Dissecting the Interferon-Induced Inhibition of Hepatitis C Virus Replication by Using a Novel Host Cell Line , 2005, Journal of Virology.
[7] M. Carmo-Fonseca,et al. SUMO-1 modification alters ADAR1 editing activity. , 2005, Molecular biology of the cell.
[8] S. Hammond. Dicing and slicing , 2005, FEBS letters.
[9] Anne Gatignol,et al. TRBP, a regulator of cellular PKR and HIV‐1 virus expression, interacts with Dicer and functions in RNA silencing , 2005, EMBO reports.
[10] Arvin C. Dar,et al. Higher-Order Substrate Recognition of eIF2α by the RNA-Dependent Protein Kinase PKR , 2005, Cell.
[11] Susan S. Taylor,et al. PKR and eIF2α: Integration of Kinase Dimerization, Activation, and Substrate Docking , 2005, Cell.
[12] Arvin C. Dar,et al. Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition , 2005, Cell.
[13] A. Rich,et al. Modulation of ADAR1 editing activity by Z-RNA in vitro , 2005, Nucleic acids research.
[14] Weida Huang,et al. High doses of siRNAs induce eri-1 and adar-1 gene expression and reduce the efficiency of RNA interference in the mouse. , 2005, The Biochemical journal.
[15] B. Bass,et al. Inositol Hexakisphosphate Is Bound in the ADAR2 Core and Required for RNA Editing , 2005, Science.
[16] J. Casey,et al. Effects of Conserved RNA Secondary Structures on Hepatitis Delta Virus Genotype I RNA Editing, Replication, and Virus Production , 2005, Journal of Virology.
[17] J. Corbett,et al. Encephalomyocarditis Virus Induces PKR-Independent Mitogen-Activated Protein Kinase Activation in Macrophages , 2005, Journal of Virology.
[18] P. Kao,et al. ADAR1 Interacts with NF90 through Double-Stranded RNA and Regulates NF90-Mediated Gene Expression Independently of RNA Editing , 2005, Molecular and Cellular Biology.
[19] Toshiaki Maruyama,et al. Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.
[20] K. Taira,et al. Analysis of Double-stranded RNA-induced Apoptosis Pathways Using Interferon-response Noninducible Small Interfering RNA Expression Vector Library* , 2005, Journal of Biological Chemistry.
[21] B. Williams,et al. RNA-Dependent Protein Kinase Is Required for Alpha-1 Interferon Transgene-Induced Resistance to Genital Herpes Simplex Virus Type 2 , 2005, Journal of Virology.
[22] R. Bartenschlager,et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.
[23] Xiaowei Yang,et al. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[24] Daniel R. Clutterbuck,et al. A bioinformatic screen for novel A-I RNA editing sites reveals recoding editing in BC10 , 2005, Bioinform..
[25] M. Mayer,et al. Glutamate receptor ion channels , 2005, Current Opinion in Neurobiology.
[26] H. Shimizu,et al. Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. , 2005, The Journal of investigative dermatology.
[27] G. Barber. The dsRNA-dependent protein kinase, PKR and cell death , 2005, Cell Death and Differentiation.
[28] M. Puig,et al. New Antiviral Pathway That Mediates Hepatitis C Virus Replicon Interferon Sensitivity through ADAR1 , 2005, Journal of Virology.
[29] M. Gale,et al. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[30] C. Samuel,et al. Expression of Interferon-inducible RNA Adenosine Deaminase ADAR1 during Pathogen Infection and Mouse Embryo Development Involves Tissue-selective Promoter Utilization and Alternative Splicing* , 2005, Journal of Biological Chemistry.
[31] Yan Zhou,et al. Double‐stranded RNA‐dependent protein kinase (PKR) is downregulated by phorbol ester , 2005, The FEBS journal.
[32] F. Sicheri,et al. PKR and GCN2 Kinases and Guanine Nucleotide Exchange Factor Eukaryotic Translation Initiation Factor 2B (eIF2B) Recognize Overlapping Surfaces on eIF2α , 2005, Molecular and Cellular Biology.
[33] S. Akira,et al. Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway during Hepatitis C Virus Expression and Restoration of Signaling by IKKε , 2005, Journal of Virology.
[34] L. Graves,et al. Peroxisome Proliferator-activated Receptor γ-independent Activation of p38 MAPK by Thiazolidinediones Involves Calcium/Calmodulin-dependent Protein Kinase II and Protein Kinase R , 2005, Journal of Biological Chemistry.
[35] M. Trottier,et al. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. , 2005, Virology.
[36] J. M. Cameron,et al. The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response. , 2005, Virology.
[37] Jun Wang,et al. Identification of a novel mutation in the DSRAD gene in a Chinese pedigree with dyschromatosis symmetrica hereditaria , 2005, Archives of Dermatological Research.
[38] Rekha C. Patel,et al. Identification of the heparin‐binding domains of the interferon‐induced protein kinase, PKR , 2005, The FEBS journal.
[39] Erez Y. Levanon,et al. Evolutionarily conserved human targets of adenosine to inosine RNA editing , 2005, Nucleic acids research.
[40] Zuo Zhang,et al. Vigilins Bind to Promiscuously A-to-I-Edited RNAs and Are Involved in the Formation of Heterochromatin , 2005, Current Biology.
[41] K. Nishikura,et al. ADAR1 RNA Deaminase Limits Short Interfering RNA Efficacy in Mammalian Cells* , 2005, Journal of Biological Chemistry.
[42] C. Proud. eIF2 and the control of cell physiology. , 2005, Seminars in cell & developmental biology.
[43] Xuejun Zhang,et al. Two frameshift mutations in the RNA-specific adenosine deaminase gene associated with dyschromatosis symmetrica hereditaria. , 2005, Archives of dermatology.
[44] Monica Hultcrantz,et al. RNase L and Double-Stranded RNA-Dependent Protein Kinase Exert Complementary Roles in Islet Cell Defense during Coxsackievirus Infection1 , 2005, The Journal of Immunology.
[45] Wen‐yuan Zhu,et al. A new arginine substitution mutation of DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria. , 2005, Journal of dermatological science.
[46] A. Rich,et al. A PKR-like eukaryotic initiation factor 2alpha kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[47] Y. Kawahara,et al. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis , 2005, Journal of Molecular Medicine.
[48] Y. Kon,et al. The mRNA regulation of porcine double-stranded RNA-activated protein kinase gene. , 2004, The Journal of veterinary medical science.
[49] N. Sonenberg,et al. Resistance to Vesicular Stomatitis Virus Infection Requires a Functional Cross Talk between the Eukaryotic Translation Initiation Factor 2α Kinases PERK and PKR , 2004, Journal of Virology.
[50] Michael B. Mathews,et al. The double-stranded-RNA-binding motif: interference and much more , 2004, Nature Reviews Molecular Cell Biology.
[51] Alexander Rich,et al. Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome , 2004, PLoS biology.
[52] Weiran Zhang,et al. Cells Lacking NF-κB or in Which NF-κB Is Not Activated Vary with Respect to Ability To Sustain Herpes Simplex Virus 1 Replication and Are Not Susceptible to Apoptosis Induced by a Replication-Incompetent Mutant Virus , 2004, Journal of Virology.
[53] M. Esteban,et al. Vaccinia virus recombinants as a model system to analyze interferon-induced pathways. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[54] Xiaoling Zhang,et al. The Fanconi Anemia Proteins Functionally Interact with the Protein Kinase Regulated by RNA (PKR)* , 2004, Journal of Biological Chemistry.
[55] W. Blalock,et al. Serine 18 Phosphorylation of RAX, the PKR Activator, Is Required for PKR Activation and Consequent Translation Inhibition* , 2004, Journal of Biological Chemistry.
[56] A. Rich,et al. A poxvirus protein forms a complex with left-handed Z-DNA: crystal structure of a Yatapoxvirus Zalpha bound to DNA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] Yi-Bing Zhang,et al. Molecular cloning and characterisation of a fish PKR-like gene from cultured CAB cells induced by UV-inactivated virus. , 2004, Fish & shellfish immunology.
[58] H. Kirchner,et al. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection. , 2004, Journal of hepatology.
[59] T. Tuschl,et al. Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.
[60] Joshua J C Rosenthal,et al. Control of human potassium channel inactivation by editing of a small mRNA hairpin , 2004, Nature Structural &Molecular Biology.
[61] B. Williams,et al. Protein Kinase R (PKR) Interacts with and Activates Mitogen-activated Protein Kinase Kinase 6 (MKK6) in Response to Double-stranded RNA Stimulation* , 2004, Journal of Biological Chemistry.
[62] M. Gao,et al. A novel mutation of the DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria , 2004, Clinical and experimental dermatology.
[63] T. Matise,et al. Widespread RNA editing of embedded alu elements in the human transcriptome. , 2004, Genome research.
[64] G. Carmichael,et al. Effects of Length and Location on the Cellular Response to Double-Stranded RNA , 2004, Microbiology and Molecular Biology Reviews.
[65] Zipora Y. Fligelman,et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.
[66] Shuji Sato,et al. By Inhibiting Replication, the Large Hepatitis Delta Antigen Can Indirectly Regulate Amber/W Editing and Its Own Expression , 2004, Journal of Virology.
[67] J. Langland,et al. Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. , 2004, Virology.
[68] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[69] Xuejun Zhang,et al. Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH) , 2004, Human mutation.
[70] H. Nakano,et al. TRAF Family Proteins Link PKR with NF-κB Activation , 2004, Molecular and Cellular Biology.
[71] K. Nishikura,et al. Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy. , 2004, Brain research. Molecular brain research.
[72] N. McMillan,et al. Loss of PKR activity in chronic lymphocytic leukemia , 2004, International journal of cancer.
[73] X. Zhang,et al. Refined localization of dyschromatosis symmetrica hereditaria gene to a 9·4‐cM region at 1q21–22 and a literature review of 136 cases reported in China , 2004, The British journal of dermatology.
[74] Li Jiang,et al. Novel mutations of the RNA-specific adenosine deaminase gene (DSRAD) in Chinese families with dyschromatosis symmetrica hereditaria. , 2004, The Journal of investigative dermatology.
[75] Y. Nie,et al. Subcellular Distribution of ADAR1 Isoforms Is Synergistically Determined by Three Nuclear Discrimination Signals and a Regulatory Motif* , 2004, Journal of Biological Chemistry.
[76] M. Karin,et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.
[77] M. Tohyama,et al. An RNA‐dependent protein kinase is involved in tunicamycin‐induced apoptosis and Alzheimer's disease , 2004, The EMBO journal.
[78] C. Samuel,et al. DNA Damage-binding Proteins and Heterogeneous Nuclear Ribonucleoprotein A1 Function as Constitutive KCS Element Components of the Interferon-inducible RNA-dependent Protein Kinase Promoter* , 2004, Journal of Biological Chemistry.
[79] N. Sonenberg,et al. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs , 2004, The EMBO journal.
[80] P. Seeburg,et al. Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1* , 2004, Journal of Biological Chemistry.
[81] M. Weiss,et al. Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene* , 2004, Journal of Biological Chemistry.
[82] Brenda L Bass,et al. Mutations in RNAi Rescue Aberrant Chemotaxis of ADAR Mutants , 2003, Science.
[83] C. Gélinas,et al. To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis , 2003, Oncogene.
[84] Y. Nie,et al. Intracellular Localization of Differentially Regulated RNA-specific Adenosine Deaminase Isoforms in Inflammation* , 2003, Journal of Biological Chemistry.
[85] I. Greger,et al. AMPA Receptor Tetramerization Is Mediated by Q/R Editing , 2003, Neuron.
[86] Weiran Zhang,et al. Activation of NF-κB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[87] G. Cheng,et al. Dephosphorylation of eIF-2α Mediated by the γ134.5 Protein of Herpes Simplex Virus Type 1 Is Required for Viral Response to Interferon but Is Not Sufficient for Efficient Viral Replication , 2003, Journal of Virology.
[88] B. Sherry,et al. PKR's protective role in viral myocarditis. , 2003, Virology.
[89] A. Mercer,et al. The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo. , 2003, Virology.
[90] Tamio Suzuki,et al. Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. , 2003, American journal of human genetics.
[91] C. Samuel,et al. The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. , 2003, Virology.
[92] S. Krishnamurthy,et al. Newcastle Disease Virus V Protein Is Associated with Viral Pathogenesis and Functions as an Alpha Interferon Antagonist , 2003, Journal of Virology.
[93] R. Reenan,et al. Nervous System Targets of RNA Editing Identified by Comparative Genomics , 2003, Science.
[94] M. Clemens,et al. Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA. , 2003, RNA.
[95] M. O’Connell,et al. An ADAR that edits transcripts encoding ion channel subunits functions as a dimer , 2003, The EMBO journal.
[96] P. Seeburg,et al. Regulation of ion channel/neurotransmitter receptor function by RNA editing , 2003, Current Opinion in Neurobiology.
[97] A. Rich,et al. A role for Z-DNA binding in vaccinia virus pathogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[98] B. Williams,et al. Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.
[99] John M. Murray,et al. Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA* , 2003, The Journal of Biological Chemistry.
[100] Y. Nie,et al. Widespread inosine‐containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation , 2003, Immunology.
[101] M. Carmo-Fonseca,et al. Dynamic association of RNA-editing enzymes with the nucleolus , 2003, Journal of Cell Science.
[102] Xiao-yan Xiong,et al. Identification of a locus for dyschromatosis symmetrica hereditaria at chromosome 1q11-1q21. , 2003, The Journal of investigative dermatology.
[103] A. Bridgen,et al. Activation of PKR by Bunyamwera Virus Is Independent of the Viral Interferon Antagonist NSs , 2003, Journal of Virology.
[104] Johnm . Taylor,et al. Replication of human hepatitis delta virus: recent developments. , 2003, Trends in microbiology.
[105] C. Samuel,et al. Functional analysis of the KCS-like element of the interferon-inducible RNA-specific adenosine deaminase ADAR1 promoter. , 2003, Gene.
[106] C. Horvath,et al. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. , 2002, Virology.
[107] R. Chang,et al. Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration , 2002, Journal of neurochemistry.
[108] J. Casey,et al. Inhibition of Hepatitis Delta Virus RNA Editing by Short Inhibitory RNA-Mediated Knockdown of ADAR1 but Not ADAR2 Expression , 2002, Journal of Virology.
[109] B. Bass,et al. RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans , 2002, The EMBO journal.
[110] M. Hallegger,et al. Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. , 2002, Molecular biology of the cell.
[111] D. Lazinski,et al. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[112] K. Gardiner,et al. Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns. , 2002, Gene.
[113] C. Collins,et al. Adenosine to Inosine Editing by ADAR2 Requires Formation of a Ternary Complex on the GluR-B R/G Site* , 2002, The Journal of Biological Chemistry.
[114] B. Bass,et al. The role of RNA editing by ADARs in RNAi. , 2002, Molecular cell.
[115] K. Eguchi,et al. p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells. , 2002, Journal of hepatology.
[116] C. Samuel,et al. Tissue Selectivity of Interferon-Stimulated Gene Expression in Mice Infected with Dam+ versus Dam−Salmonella enterica Serovar Typhimurium Strains , 2002, Infection and Immunity.
[117] M. Katze,et al. The Direct Binding of the Catalytic Subunit of Protein Phosphatase 1 to the PKR Protein Kinase Is Necessary but Not Sufficient for Inactivation and Disruption of Enzyme Dimer Formation* , 2002, The Journal of Biological Chemistry.
[118] Gozoh Tsujimoto,et al. Two Novel Transcripts for Human Endothelin B Receptor Produced by RNA Editing/Alternative Splicing from a Single Gene* , 2002, The Journal of Biological Chemistry.
[119] Michael G. Katze,et al. Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.
[120] F. Sicheri,et al. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. , 2002, Molecular cell.
[121] C. Samuel,et al. The promoter-proximal KCS element of the PKR kinase gene enhances transcription irrespective of orientation and position relative to the ISRE element and is functionally distinct from the KCS-like element of the ADAR deaminase Promoter. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[122] B. Williams,et al. Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[123] P. Seeburg. A-to-I Editing New and Old Sites, Functions and Speculations , 2002, Neuron.
[124] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[125] J. Casey,et al. Increased RNA Editing and Inhibition of Hepatitis Delta Virus Replication by High-Level Expression of ADAR1 and ADAR2 , 2002, Journal of Virology.
[126] F. Chisari,et al. Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice , 2002, Journal of Virology.
[127] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[128] S. Goodbourn,et al. Degradation of STAT1 and STAT2 by the V Proteins of Simian Virus 5 and Human Parainfluenza Virus Type 2, Respectively: Consequences for Virus Replication in the Presence of Alpha/Beta and Gamma Interferons , 2002, Journal of Virology.
[129] Peter Vandenabeele,et al. Translation Inhibition in Apoptosis , 2001, The Journal of Biological Chemistry.
[130] J. Kjems,et al. CRM1 Mediates the Export of ADAR1 through a Nuclear Export Signal within the Z-DNA Binding Domain , 2001, Molecular and Cellular Biology.
[131] M. Diamond,et al. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. , 2001, Virology.
[132] C. Samuel,et al. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity. , 2001, Virology.
[133] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[134] A. Herbert,et al. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[135] C. Samuel,et al. Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.
[136] O. Donzé,et al. The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA‐dependent kinase PKR , 2001, The EMBO journal.
[137] K. Ozato,et al. Heterologous dimerization domains functionally substitute for the double‐stranded RNA binding domains of the kinase PKR , 2001, The EMBO journal.
[138] M. Hayden,et al. Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. , 2001, Human molecular genetics.
[139] A. Hinnebusch,et al. Binding of Double-stranded RNA to Protein Kinase PKR Is Required for Dimerization and Promotes Critical Autophosphorylation Events in the Activation Loop* , 2001, The Journal of Biological Chemistry.
[140] Paul J. Harrison,et al. RNA editing of the 5-HT2C receptor is reduced in schizophrenia , 2001, Molecular Psychiatry.
[141] M. Jantsch,et al. The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. , 2001, Molecular biology of the cell.
[142] T. Date,et al. Expression of unphosphorylated form of human double-stranded RNA-activated protein kinase in Escherichia coli. , 2001, Biochemical and biophysical research communications.
[143] R. Sperling,et al. RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[144] Colleen M Niswender,et al. RNA Editing of the Human Serotonin 5-HT2C Receptor: Alterations in Suicide and Implications for Serotonergic Pharmacotherapy , 2001, Neuropsychopharmacology.
[145] A. Koromilas,et al. Dominant Negative Function by an Alternatively Spliced Form of the Interferon-inducible Protein Kinase PKR* , 2001, The Journal of Biological Chemistry.
[146] H. Kwon,et al. Activation of the IκBα kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR , 2001, Oncogene.
[147] S. Fagerlie,et al. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. , 2001, Blood.
[148] G. Barber. Host defense, viruses and apoptosis , 2001, Cell Death and Differentiation.
[149] M. Esteban,et al. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-κB activation , 2001, Oncogene.
[150] B. Jacobs,et al. Both Carboxy- and Amino-Terminal Domains of the Vaccinia Virus Interferon Resistance Gene, E3L, Are Required for Pathogenesis in a Mouse Model , 2001, Journal of Virology.
[151] M. Iordanov,et al. Activation of NF-κB by Double-Stranded RNA (dsRNA) in the Absence of Protein Kinase R and RNase L Demonstrates the Existence of Two Separate dsRNA-Triggered Antiviral Programs , 2001, Molecular and Cellular Biology.
[152] I. Mohr,et al. Inhibition of PKR Activation by the Proline-Rich RNA Binding Domain of the Herpes Simplex Virus Type 1 Us11 Protein , 2000, Journal of Virology.
[153] K. Nishikura,et al. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. , 2000, Science.
[154] Rekha C. Patel,et al. PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR* , 2000, The Journal of Biological Chemistry.
[155] C. Samuel,et al. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. , 2000, Gene.
[156] C. Samuel,et al. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[157] S. Nanduri,et al. A dynamically tuned double‐stranded RNA binding mechanism for the activation of antiviral kinase PKR , 2000, The EMBO journal.
[158] N. Sonenberg,et al. The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus , 2000, Journal of Virology.
[159] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[160] M. Bhave,et al. Regulation of oxytocin receptor gene expression in sheep: tissue specificity, multiple transcripts and mRNA editing. , 2000, Journal of reproduction and fertility.
[161] R. Reenan,et al. A-to-I Pre-mRNA Editing in Drosophila Is Primarily Involved in Adult Nervous System Function and Integrity , 2000, Cell.
[162] B. Williams,et al. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.
[163] C. Samuel,et al. Assignment1 of the RNA-specific adenosine deaminase gene (Adar) to mouse chromosome 3F2 by in situ hybridization , 2000, Cytogenetic and Genome Research.
[164] D. Feldmeyer,et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2 , 2000, Nature.
[165] E. Meurs,et al. PKR Stimulates NF-κB Irrespective of Its Kinase Function by Interacting with the IκB Kinase Complex , 2000, Molecular and Cellular Biology.
[166] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[167] M. Katze,et al. Translational Control of Viral Gene Expression in Eukaryotes , 2000, Microbiology and Molecular Biology Reviews.
[168] K. Nishikura,et al. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. , 2000, RNA.
[169] M. Mathews,et al. Proteins binding to duplexed RNA: one motif, multiple functions. , 2000, Trends in biochemical sciences.
[170] C. Samuel,et al. Mouse interferon-inducible RNA-dependent protein kinase Pkr gene: cloning and sequence of the 5'-flanking region and functional identification of the minimal inducible promoter. , 2000, Gene.
[171] M. Esteban,et al. Activation of NF-κB by the dsRNA-dependent protein kinase, PKR involves the IκB kinase complex , 2000, Oncogene.
[172] K. Nishikura,et al. Altered G Protein‐Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin2C Receptors , 2000, Journal of neurochemistry.
[173] B. Williams,et al. NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase , 2000, Molecular and Cellular Biology.
[174] S. Goodbourn,et al. The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation , 1999, Journal of Virology.
[175] M. Karin,et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. , 1999, Immunity.
[176] K. Kuhen,et al. Alternative splice variants of the human PKR protein kinase possessing different 5'-untranslated regions: expression in untreated and interferon-treated cells and translational activity. , 1999, Virology.
[177] M. Adelson,et al. Inhibition of Replication of Reactivated Human Immunodeficiency Virus Type 1 (HIV-1) in Latently Infected U1 Cells Transduced with an HIV-1 Long Terminal Repeat-Driven PKR cDNA Construct , 1999, Journal of Virology.
[178] R. Kaufman,et al. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[179] A. Lau,et al. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[180] C. de Haro,et al. Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. , 1999, European journal of biochemistry.
[181] N. Kudo,et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[182] P. Hartig,et al. Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor , 1999, Neuropsychopharmacology.
[183] W. Guo,et al. DRBP76, a Double-stranded RNA-binding Nuclear Protein, Is Phosphorylated by the Interferon-induced Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.
[184] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[185] M. Esteban,et al. Induction of Apoptosis by Double-Stranded-RNA-Dependent Protein Kinase (PKR) Involves the α Subunit of Eukaryotic Translation Initiation Factor 2 and NF-κB , 1999, Molecular and Cellular Biology.
[186] R. Emeson,et al. Serotonin-2C Receptor Pre-mRNA Editing in Rat Brain andin Vitro by Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1* , 1999, The Journal of Biological Chemistry.
[187] A. Rich,et al. Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. , 1999, Science.
[188] Mingli Yang,et al. RAX, a Cellular Activator for Double-stranded RNA-dependent Protein Kinase during Stress Signaling* , 1999, The Journal of Biological Chemistry.
[189] B. Bass,et al. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[190] P. Kao,et al. Nuclear factor-90 of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. , 1999, Biochemistry.
[191] T. Dawson,et al. Regulation of alternative splicing by RNA editing , 1999, Nature.
[192] C. Samuel,et al. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[193] Colleen M. Niswender,et al. RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity* , 1999, The Journal of Biological Chemistry.
[194] A. Cuddihy,et al. Double-Stranded-RNA-Activated Protein Kinase PKR Enhances Transcriptional Activation by Tumor Suppressor p53 , 1999, Molecular and Cellular Biology.
[195] D. Rebouillat,et al. The human 2',5'-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[196] C. Samuel,et al. Characterization of the 5'-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. , 1999, Gene.
[197] H. Atkins,et al. Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.
[198] M. Jantsch,et al. The RNA-editing Enzyme ADAR1 Is Localized to the Nascent Ribonucleoprotein Matrix on Xenopus Lampbrush Chromosomes but Specifically Associates with an Atypical Loop , 1999, The Journal of cell biology.
[199] Yong Liu,et al. Editing of Glutamate Receptor Subunit B Pre-mRNA by Splice-site Variants of Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1* , 1999, The Journal of Biological Chemistry.
[200] M. Katze,et al. The Cellular Inhibitor of the PKR Protein Kinase, P58IPK, Is an Influenza Virus-activated Co-chaperone That Modulates Heat Shock Protein 70 Activity* , 1999, The Journal of Biological Chemistry.
[201] K. Kuhen,et al. Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. , 1999, Virology.
[202] D. Ron,et al. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase , 1999, Nature.
[203] K. Kuhen,et al. Mechanism of Interferon Action: Identification of Essential Positions within the Novel 15-Base-Pair KCS Element Required for Transcriptional Activation of the RNA-Dependent Protein Kinasepkr Gene , 1998, Journal of Virology.
[204] T. Mak,et al. Activation of the dsRNA‐dependent protein kinase, PKR, induces apoptosis through FADD‐mediated death signaling , 1998, The EMBO journal.
[205] M. Jaramillo,et al. The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia. , 1998, Experimental cell research.
[206] B. Roizman,et al. The Herpes Simplex Virus US11 Protein Effectively Compensates for the γ134.5 Gene if Present before Activation of Protein Kinase R by Precluding Its Phosphorylation and That of the α Subunit of Eukaryotic Translation Initiation Factor 2 , 1998, Journal of Virology.
[207] Tyson V. Sharp,et al. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. , 1998, Virology.
[208] B. Williams,et al. Structure of the double‐stranded RNA‐binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA‐mediated activation , 1998, The EMBO journal.
[209] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[210] E. Paoletti,et al. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[211] G. Sen,et al. PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.
[212] A. Rich,et al. Double-stranded RNA-specific adenosine deaminase: nucleic acid binding properties. , 1998, Methods.
[213] C. Samuel,et al. Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase. , 1998, Virology.
[214] T. Cech,et al. Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. , 1998, Biochemistry.
[215] R. Schreiber,et al. Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.
[216] C. Rivas,et al. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme. , 1998, Virology.
[217] A. Hinnebusch,et al. Autophosphorylation in the Activation Loop Is Required for Full Kinase Activity In Vivo of Human and Yeast Eukaryotic Initiation Factor 2α Kinases PKR and GCN2 , 1998, Molecular and Cellular Biology.
[218] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[219] M. Katze,et al. Regulation of Interferon-Induced Protein Kinase PKR: Modulation of P58IPK Inhibitory Function by a Novel Protein, P52rIPK , 1998, Molecular and Cellular Biology.
[220] R. Kaufman,et al. Phosphorylation of Eukaryotic Translation Initiation Factor 2 Mediates Apoptosis in Response to Activation of the Double-stranded RNA-dependent Protein Kinase* , 1998, The Journal of Biological Chemistry.
[221] C. Schmid,et al. Potential Alu Function: Regulation of the Activity of Double-Stranded RNA-Activated Kinase PKR , 1998, Molecular and Cellular Biology.
[222] B. Jacobs,et al. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. , 1997, Virology.
[223] J. Radosevich,et al. Interferon-Responsive Protein Kinase (p68) and Proliferating Cell Nuclear Antigen Are Inversely Distributed in Head and Neck Squamous Cell Carcinoma , 1997, Tumor Biology.
[224] M. Ghoneum,et al. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein Kinase RNA , 1997, Journal of internal medicine.
[225] Tyson V. Sharp,et al. Homologous regions of the alpha subunit of eukaryotic translational initiation factor 2 (eIF2alpha) and the vaccinia virus K3L gene product interact with the same domain within the dsRNA-activated protein kinase (PKR). , 1997, European journal of biochemistry.
[226] J. Darnell. STATs and gene regulation. , 1997, Science.
[227] M J Clemens,et al. The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[228] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[229] I. Mian,et al. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[230] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[231] J. Silverman,et al. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha , 1997, Molecular and cellular biology.
[232] R. Emeson,et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.
[233] K. Nishikura,et al. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases , 1997, Molecular and cellular biology.
[234] C. Smith,et al. A ribonuclease specific for inosine‐containing RNA: a potential role in antiviral defence? , 1997, The EMBO journal.
[235] Madhur Kumar,et al. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[236] K. Kuhen,et al. The PKR protein kinase--an interferon-inducible regulator of cell growth and differentiation. , 1997, International journal of hematology.
[237] S. Der,et al. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[238] M. Mathews,et al. Surprising specificity of PKR binding to delta agent genomic RNA. , 1997, RNA.
[239] B. Bass,et al. Analysis of Xenopus dsRNA adenosine deaminase cDNAs reveals similarities to DNA methyltransferases. , 1997, RNA.
[240] A. Cuddihy,et al. Physical association between STAT1 and the interferon‐inducible protein kinase PKR and implications for interferon and double‐stranded RNA signaling pathways , 1997, The EMBO journal.
[241] J. Langland,et al. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells , 1997, Journal of virology.
[242] Yong Liu,et al. Functionally Distinct Double-stranded RNA-binding Domains Associated with Alternative Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase* , 1997, The Journal of Biological Chemistry.
[243] B. Roizman,et al. The γ134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase , 1997 .
[244] K. Jeang,et al. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA‐dependent protein kinase PKR , 1997, The EMBO journal.
[245] B. Williams,et al. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF‐1 and NF‐κB , 1997, The EMBO journal.
[246] M. Katze,et al. The molecular chaperone hsp40 regulates the activity of P58IPK, the cellular inhibitor of PKR. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[247] K. Kuhen,et al. Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes. , 1997, Virology.
[248] B. Jacobs,et al. Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene. , 1997, Virology.
[249] K. Colley,et al. Two Naturally Occurring α2,6-Sialyltransferase Forms with a Single Amino Acid Change in the Catalytic Domain Differ in Their Catalytic Activity and Proteolytic Processing* , 1997, The Journal of Biological Chemistry.
[250] M. Katze,et al. The 58-kDa Cellular Inhibitor of the Double Stranded RNA-dependent Protein Kinase Requires the Tetratricopeptide Repeat 6 and DnaJ Motifs to Stimulate Protein Synthesis in Vivo* , 1996, The Journal of Biological Chemistry.
[251] A. Hinnebusch,et al. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR , 1996, Molecular and cellular biology.
[252] T. Takizawa,et al. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection , 1996, Journal of virology.
[253] A. Lau,et al. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[254] M. Mathews,et al. Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA I. , 1996, RNA.
[255] K. Kuhen,et al. Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. , 1996, Genomics.
[256] M. Mathews,et al. Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach , 1996, Journal of virology.
[257] M. Katze,et al. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation , 1996, Molecular and cellular biology.
[258] T. Komatsu,et al. Interferon-γ induced type I nitric oxide synthase activity inhibits viral replication in neurons , 1996, Journal of Neuroimmunology.
[259] C. Samuel,et al. Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. , 1996, Virology.
[260] P. Seeburg,et al. Structural Requirements for RNA Editing in Glutamate Receptor Pre-mRNAs by Recombinant Double-stranded RNA Adenosine Deaminase (*) , 1996, The Journal of Biological Chemistry.
[261] P. Seeburg,et al. Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[262] C. Samuel,et al. Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase , 1996, Journal of virology.
[263] P. Seeburg,et al. A mammalian RNA editing enzyme , 1996, Nature.
[264] H. Margolis,et al. Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.
[265] Dwight C. Look,et al. Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.
[266] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[267] J. Bagg,et al. Seroepidemiology of herpes virus infections among dental personnel. , 1995, Journal of dentistry.
[268] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[269] K. Nishikura,et al. Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. , 1995, Journal of molecular biology.
[270] S. Akbarian,et al. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia , 1995, Brain Research.
[271] C. Samuel,et al. The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. , 1995, Genomics.
[272] T. Mak,et al. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. , 1995, Virology.
[273] H. W. Chang,et al. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L , 1995, Journal of virology.
[274] C. Samuel,et al. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.
[275] C. Samuel,et al. Mechanism of interferon action: characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase , 1995, Journal of virology.
[276] M. Mathews,et al. Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I).poly (C) in endothelial cells. , 1995, European journal of biochemistry.
[277] N. Sonenberg,et al. Abrogation of translation initiation factor eIF‐2 phosphorylation causes malignant transformation of NIH 3T3 cells. , 1995, The EMBO journal.
[278] T. Takizawa,et al. Transcription Stimulation of the Fas-encoding Gene by Nuclear Factor for Interleukin-6 Expression upon Influenza Virus Infection (*) , 1995, The Journal of Biological Chemistry.
[279] K. Nishikura,et al. Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts (*) , 1995, The Journal of Biological Chemistry.
[280] C. Samuel,et al. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. , 1995, Virology.
[281] J. Scott,et al. A place in the world for RNA editing , 1995, Cell.
[282] M. Katze,et al. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation , 1995, Molecular and cellular biology.
[283] T. Pilot‐Matias,et al. Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.
[284] T. Hunter,et al. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[285] R. Emeson,et al. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine , 1995, Science.
[286] F. Blaney,et al. 5-HT2 receptor subtypes: a family re-united? , 1995, Trends in pharmacological sciences.
[287] M. Higuchi,et al. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase , 1995, Molecular and cellular biology.
[288] C. Samuel,et al. Sequence of the murine interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones. , 1995, Gene.
[289] M. Katze. Regulation of the interferon-induced PKR: can viruses cope? , 1995, Trends in microbiology.
[290] C. Samuel,et al. Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR--determination of KD values for VAI and TAR RNAs. , 1995, Virology.
[291] A. Hinnebusch,et al. Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.
[292] T Kuner,et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. , 1994, Science.
[293] R. Cattaneo,et al. Biased (A-->I) hypermutation of animal RNA virus genomes. , 1994, Current opinion in genetics & development.
[294] I. Behrmann,et al. Structure of the human APO‐1 gene , 1994, European journal of immunology.
[295] K. Nishikura,et al. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[296] S. Kimball,et al. Cloning and characterization of a cDNA encoding rat PKR, the double-stranded RNA-dependent eukaryotic initiation factor-2 kinase. , 1994, Biochimica et biophysica acta.
[297] J. Inazawa,et al. Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.
[298] C. Samuel,et al. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[299] G. Sen,et al. Role of the amino-terminal residues of the interferon-induced protein kinase in its activation by double-stranded RNA and heparin. , 1994, The Journal of biological chemistry.
[300] Aseem Kumar,et al. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[301] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.
[302] D. Speicher,et al. Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. , 1994, The Journal of biological chemistry.
[303] M. Katze,et al. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins , 1994, Molecular and cellular biology.
[304] D. Fujiwara,et al. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. , 1994, The Journal of biological chemistry.
[305] S. B. Lee,et al. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. , 1994, Virology.
[306] R. Wolfenden,et al. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. , 1994, Journal of molecular biology.
[307] P. Seeburg,et al. RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency , 1993, Cell.
[308] C. Samuel,et al. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR , 1993, Journal of virology.
[309] H. Budka,et al. Clonal expansion of hypermutated measles virus in a SSPE brain. , 1993, Virology.
[310] G. Ghadge,et al. Expression of the double-stranded RNA-dependent protein kinase (p68) in squamous cell carcinoma of the head and neck region. , 1993, Archives of otolaryngology--head & neck surgery.
[311] M. Mathews,et al. Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. , 1993, Journal of cell science.
[312] B. Moss,et al. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. , 1993, Virology.
[313] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[314] O. Elroy-Stein,et al. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. , 1993, The Journal of biological chemistry.
[315] H. W. Chang,et al. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. , 1993, Virology.
[316] C. Disteche,et al. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PRKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. , 1993, Genomics.
[317] C. Samuel,et al. The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.
[318] S. B. Lee,et al. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. , 1993, Virology.
[319] G. Ghadge,et al. Expression of the protein kinase p-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.
[320] M. Mathews,et al. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. , 1992, Genes & development.
[321] C. Samuel,et al. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[322] M. Mathews,et al. Interactions between double-stranded RNA regulators and the protein kinase DAI , 1992, Molecular and cellular biology.
[323] M. Katze,et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.
[324] M. Katze,et al. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.
[325] M. Katze,et al. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. , 1992, The Journal of biological chemistry.
[326] G. Feng,et al. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[327] H. W. Chang,et al. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[328] C. Samuel,et al. Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. , 1992, Virology.
[329] C. Samuel,et al. Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. , 1992, Virology.
[330] P. Lengyel,et al. The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.
[331] B. Sakmann,et al. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit , 1992, Neuron.
[332] M. Katze,et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system , 1991, Molecular and cellular biology.
[333] M. Mathews,et al. Adenovirus virus-associated RNA and translation control , 1991, Journal of virology.
[334] M. Katze,et al. Functional expression and characterization of the interferon-induced double-stranded RNA activated P68 protein kinase from Escherichia coli. , 1991, Biochemistry.
[335] Ding‐Shinn Chen,et al. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[336] I. London,et al. Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2 alpha (eIF-2 alpha) kinase of rabbit reticulocytes: homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2 alpha kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[337] P. Gros,et al. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. , 1991, The Journal of biological chemistry.
[338] C. Samuel,et al. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.
[339] F A Quiocho,et al. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. , 1991, Science.
[340] J. Glenn,et al. trans-dominant inhibition of human hepatitis delta virus genome replication , 1991, Journal of virology.
[341] K. Dimock,et al. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. , 1991, Virology.
[342] K. Khalili,et al. Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. , 1990, Molecular and cellular biology.
[343] J. Taylor,et al. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication , 1990, Journal of virology.
[344] M. Lai. The molecular biology of hepatitis delta virus. , 1990, Annual review of biochemistry.
[345] M. Katze,et al. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[346] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[347] N. Sonenberg. Measures and countermeasures in the modulation of initiation factor activities by viruses. , 1990, The New biologist.
[348] J. Taylor,et al. A specific base transition occurs on replicating hepatitis delta virus RNA , 1990, Journal of virology.
[349] M. Billeter,et al. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. , 1989, Virology.
[350] C. Samuel,et al. Mechanism of interferon action. Activation of the human P1/eIF-2 alpha protein kinase by individual reovirus s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA. , 1989, Virology.
[351] J. Taylor,et al. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen , 1989, Journal of virology.
[352] G. Brawerman. mRNA decay: Finding the right targets , 1989, Cell.
[353] M. Mathews,et al. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI , 1989, Molecular and cellular biology.
[354] M. Kozak. The scanning model for translation: an update , 1989, The Journal of cell biology.
[355] Roberto Cattaneo,et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.
[356] V. Pathak,et al. Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases , 1988, Molecular and cellular biology.
[357] A. Hovanessian,et al. Autophosphorylation of the protein kinase dependent on double-stranded RNA. , 1987, The Journal of biological chemistry.
[358] A. Hovanessian,et al. The double-stranded RNA-dependent protein kinase is also activated by heparin. , 1987, European journal of biochemistry.
[359] D. Melton,et al. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity , 1987, Cell.
[360] Brenda L. Bass,et al. A developmentally regulated activity that unwinds RNA duplexes , 1987, Cell.
[361] M. Kozak. Regulation of Protein Synthesis in Virus-Infected Animal Cells , 1986, Advances in Virus Research.
[362] C. Samuel,et al. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase , 1986, Cell.
[363] Michael B. Mathews,et al. A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.
[364] M. Berry,et al. Mechanism of interferon action. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. , 1985, The Journal of biological chemistry.
[365] T. Shenk,et al. Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells , 1984, Cell.
[366] John J. Holland,et al. Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions , 1984, Cell.
[367] C. Samuel,et al. Mechanism of interferon action. Characterization of sites of phosphorylation in the interferon-induced phosphoprotein P1 from mouse fibroblasts: evidence for two forms of P1. , 1982, The Journal of biological chemistry.
[368] C. E. Samuel. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[369] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[370] Alexander Rich,et al. Left-handed Z-DNA: structure and function , 2004, Genetica.
[371] M. Mathews,et al. Phylogenetics and functions of the double-stranded RNA-binding motif: a genomic survey. , 2003, Progress in nucleic acid research and molecular biology.
[372] K. McCullough,et al. Lipopolysaccharide-induced impairment of classical swine fever virus infection in monocytic cells is sensitive to 2-aminopurine. , 2002, Antiviral research.
[373] A. Koromilas,et al. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. , 2002, Viral immunology.
[374] M. Clemens. Initiation Factor eIF2α Phosphorylation in Stress Responses and Apoptosis , 2001 .
[375] G. Sen,et al. Viruses and interferons. , 2001, Annual review of microbiology.
[376] C. Widmann,et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.
[377] R. Jagus,et al. Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. , 1999, The international journal of biochemistry & cell biology.
[378] R. Hayden,et al. Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. , 1996, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[379] C. Samuel,et al. Mechanism of Interferon Action: Biochemical and Genetic Evidence for the Intermolecular Association of the RNA-Dependent Protein Kinase PKR from Human Cells , 1996 .
[380] M. Talamonti,et al. Expression of p68 in human colon cancer. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[381] C. Samuel,et al. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. , 1994, Virology.
[382] M. Katze,et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[383] M. Billeter,et al. Mutations and A/I hypermutations in measles virus persistent infections. , 1992, Current topics in microbiology and immunology.
[384] C. Samuel,et al. Role of the RNA-dependent protein kinase in the regulated expression of genes in transfected cells. , 1992, Pharmacology & therapeutics.
[385] J. Trent,et al. Report of the committee on chromosome changes in neoplasia , 1990 .
[386] K C Zoon,et al. Interferons and their actions. , 1987, Annual review of biochemistry.
[387] Y. Kojima,et al. [Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus]. , 1958, Comptes rendus des seances de la Societe de biologie et de ses filiales.
[388] R. Sood,et al. Identification and Characterization of Pancreatic Eukaryotic Initiation Factor 2 a -Subunit Kinase, PEK, Involved in Translational Control , 2022 .